文献速递胃肠外科围术期管理与 ERAS

早期遗传咨询与CDH1突变检测改善遗传性弥漫性胃癌生存

Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
PubMed 文献 · Surgery · 2018-08-23

该研究回顾2011-2017年接受CDH1突变遗传咨询的患者注册资料,共识别21例CDH1突变者,其中52%通过多基因癌症panel诊断且无家族史。9例行全胃切除术者中最终病理8例为弥漫性胃癌。无风险认知组较家族史组更年长且转移和死亡比例更高,提示CDH1突变检测至少应启动遗传咨询并优选全胃切除术。

要点

  • 多基因panel发现的CDH1突变者常无家族史,但生物学行为同样侵袭。
  • CDH1突变者行全胃切除术后病理常证实弥漫性胃癌,术前内镜可能低估。
  • 无家族史者确诊时更易转移和死亡,早期遗传咨询与检测至关重要。

核心结论

  • CDH1突变相关遗传性弥漫性胃癌是生物学侵袭性强的胃癌亚型,仅通过多基因panel检测出的患者表现相似。
  • 检出CDH1突变至少应进行遗传咨询,并优选全胃切除术。

研究设计与样本

  • 回顾性注册研究,查询2011-2017年接受CDH1突变遗传咨询的患者资料。
  • 共识别21例CDH1突变患者。

主要发现

  • 最常见CDH1基因筛查指征为遗传性弥漫性胃癌家族史(已知风险),共10例(48%)。
  • 11例(52%)通过多基因癌症panel诊断(未知风险)。
  • 21例中9例行全胃切除术,另5例初诊时已有转移性胃癌。
  • 全胃切除组中5/9例(56%)术前筛查内镜已知胃癌,但最终病理8/9例证实弥漫性胃癌。
  • 未知风险组较家族史组更年长(中位41 vs 24岁),更易发生转移和死于该病(43% vs 29%)。

临床怎么用

  • 对检出CDH1突变者应提供遗传咨询。
  • CDH1突变者优选全胃切除术以管理胃癌风险。

局限性

  • 回顾性注册研究,样本量较小(21例)。
  • 未知风险组与家族史组的比较未报告统计学检验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hereditary diffuse gastric cancer is associated with E-cadherin (CDH1) germline mutations. The implications of CDH1 mutations detected with multigene panels in those without family history of HDGC are uncertain. METHODS: A registry of patients who underwent genetic counseling for CDH1 mutation was queried for the period 2011-2017. RESULTS: Twenty-one patients with CDH1 mutation were identified. The most common indication for CDH1 genetic screening was family history of hereditary diffuse gastric cancer (known risk) in 10 patients (48%); 11 patients (52%), however, were diagnosed by multigene cancer panels (unknown risk). Nine of the 21 patients underwent total gastrectomy, and 5 others had metastatic gastric cancer at presentation. In the gastrectomy group, 5 of the 9 patients (56%) were known to have gastric cancer based on preoperative screening endoscopy, but final pathologic examinations indicated diffuse gastric cancer in 8 of the 9 patients. The 11 patients with unknown risk for CDH1 mutation tended to be older (median 41 vs 24 years) and more likely to have metastatic disease and to die of the disease (43% vs 29%) compared with patients with family history of hereditary diffuse gastric cancer. CONCLUSION: CDH1 mutation-associated hereditary diffuse gastric cancer is a biologically aggressive variant of gastric cancer that appears to behave similarly in patients detected only by multigene panels. The detection of CDH1 mutation at a minimum warrants genetic counseling and preferably total gastrectomy.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Moslim MA, Heald B, Tu C, et al. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer. Surgery. 2018. PMID: 30145018. doi:10.1016/j.surg.2018.05.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。